A detailed history of Bellevue Group Ag transactions in Esperion Therapeutics, Inc. stock. As of the latest transaction made, Bellevue Group Ag holds 9,944,064 shares of ESPR stock, worth $22.3 Million. This represents 0.28% of its overall portfolio holdings.

Number of Shares
9,944,064
Previous 9,944,064 -0.0%
Holding current value
$22.3 Million
Previous $22.1 Million 25.68%
% of portfolio
0.28%
Previous 0.37%

Shares

23 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

BUY
$2.02 - $3.02 $11.6 Million - $17.3 Million
5,739,800 Added 136.52%
9,944,064 $26.7 Million
Q3 2023

Nov 14, 2023

SELL
$0.96 - $1.79 $3,840 - $7,160
-4,000 Reduced 0.1%
4,204,264 $4.12 Million
Q1 2023

May 15, 2023

SELL
$1.46 - $7.3 $178,120 - $890,600
-122,000 Reduced 2.82%
4,208,264 $6.69 Million
Q4 2022

Feb 14, 2023

BUY
$5.09 - $8.5 $534,450 - $892,500
105,000 Added 2.49%
4,330,264 $27 Million
Q3 2022

Nov 14, 2022

SELL
$5.45 - $8.13 $54,500 - $81,300
-10,000 Reduced 0.24%
4,225,264 $28.3 Million
Q2 2022

Aug 11, 2022

SELL
$4.77 - $6.67 $304,803 - $426,213
-63,900 Reduced 1.49%
4,235,264 $26.9 Million
Q1 2022

May 13, 2022

SELL
$3.34 - $5.56 $734,800 - $1.22 Million
-220,000 Reduced 4.87%
4,299,164 $19.9 Million
Q2 2021

Aug 12, 2021

BUY
$19.4 - $28.71 $10.3 Million - $15.2 Million
530,000 Added 13.29%
4,519,164 $95.6 Million
Q1 2021

May 12, 2021

SELL
$25.12 - $36.89 $28.9 Million - $42.4 Million
-1,149,287 Reduced 22.37%
3,989,164 $112 Million
Q4 2020

Feb 16, 2021

SELL
$24.2 - $35.76 $7.92 Million - $11.7 Million
-327,264 Reduced 5.99%
5,138,451 $134 Million
Q3 2020

Nov 16, 2020

BUY
$31.18 - $52.71 $5.07 Million - $8.57 Million
162,580 Added 3.07%
5,465,715 $203 Million
Q2 2020

Aug 13, 2020

BUY
$30.04 - $51.31 $7.97 Million - $13.6 Million
265,245 Added 5.27%
5,303,135 $272 Million
Q1 2020

May 14, 2020

BUY
$27.44 - $73.84 $14.1 Million - $37.9 Million
512,880 Added 11.33%
5,037,890 $159 Million
Q4 2019

Feb 14, 2020

BUY
$35.4 - $59.82 $10 Million - $17 Million
283,549 Added 6.69%
4,525,010 $270 Million
Q3 2019

Nov 14, 2019

BUY
$34.47 - $47.53 $6.34 Million - $8.75 Million
184,050 Added 4.54%
4,241,461 $155 Million
Q2 2019

Aug 14, 2019

BUY
$40.1 - $52.33 $143 Million - $186 Million
3,561,864 Added 718.77%
4,057,411 $189 Million
Q1 2019

May 15, 2019

BUY
$40.11 - $53.57 $1.75 Million - $2.33 Million
43,575 Added 9.64%
495,547 $19.9 Million
Q4 2018

Feb 12, 2019

BUY
$36.99 - $59.11 $2.22 Million - $3.55 Million
60,120 Added 15.34%
451,972 $20.8 Million
Q3 2018

Nov 13, 2018

BUY
$40.74 - $51.41 $3.19 Million - $4.03 Million
78,332 Added 24.98%
391,852 $17.4 Million
Q2 2018

Aug 07, 2018

BUY
$36.2 - $76.4 $5.1 Million - $10.8 Million
140,800 Added 81.52%
313,520 $12.3 Million
Q1 2018

May 09, 2018

BUY
$65.94 - $80.76 $10.9 Million - $13.3 Million
164,920 Added 2114.36%
172,720 $12.5 Million
Q4 2017

Feb 14, 2018

SELL
$43.47 - $67.43 $8,694 - $13,486
-200 Reduced 2.5%
7,800 $514,000
Q2 2017

Aug 14, 2017

BUY
N/A
8,000
8,000 $370,000

Others Institutions Holding ESPR

About Esperion Therapeutics, Inc.


  • Ticker ESPR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 66,551,600
  • Market Cap $149M
  • Description
  • Esperion Therapeutics, Inc., a pharmaceutical company, develops and commercializes medicines for the treatment of patients with elevated low density lipoprotein cholesterol. Its lead product candidates are NEXLETOL (bempedoic acid) and NEXLIZET (bempedoic acid and ezetimibe) tablets for the treatment of patients with atherosclerotic cardiovascul...
More about ESPR
Track This Portfolio

Track Bellevue Group Ag Portfolio

Follow Bellevue Group Ag and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bellevue Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Bellevue Group Ag with notifications on news.